Allarity Therapeutics, Inc. (ALLR) Free cash flow 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.8MFY2025 · since FY2020: -$7.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | +16.0% |
| FY2024 | -$17.6M | -38.5% |
| FY2023 | -$12.7M | +24.3% |
| FY2022 | -$16.8M | — |
| FY2020 | -$7.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ALLR financial trends
ALLR RevenueALLR Net incomeALLR Net marginALLR Gross profitALLR Gross marginALLR Operating incomeALLR Operating marginALLR Operating cash flowALLR Capital expendituresALLR Return on equityALLR Stock buybacksALLR Dividends paidALLR Total assetsALLR Total liabilitiesALLR Shareholders’ equityALLR overview →